Literature DB >> 7783451

Variation of multifunctional surface binding proteins--a virulence strategy for group A streptococci?

M D Boyle1.   

Abstract

Variation in surface antigens has been well recognized as a mechanism by which pathogenic organisms can avoid elimination and remain as potential pathogens in immunocompetent individuals. A variety of viral and parasitic organisms elude the immune system by varying their surface antigenic structures. Other persistent human pathogens, for example group A streptococci, are associated with cyclic variation in the severity of infections without any major change in their surface antigenic structures. Recent analysis of group A streptococcal proteins, in particular surface M and M-like proteins, has documented the existence of an array of multifunctional surface proteins which have the ability to bind to a variety of normal human plasma proteins, extracellular matrix components and human cells. The ability to change the functional activities of these surface molecules by genetic recombination among members of a closely related M protein supergene family has now been reported. In this paper, the potential importance of generating functional heterogeneity in surface binding proteins of group A streptococcus is discussed. The role of these proteins in enabling an organism to sense its environment and express the appropriate virulence factors is proposed as an explanation for the periodic changes in the frequency and severity of invasive group A streptococcal infections that can occur in the absence of a toxic-shock-like syndrome.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7783451     DOI: 10.1006/jtbi.1995.0073

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  8 in total

1.  The PA domain: a protease-associated domain.

Authors:  P Mahon; A Bateman
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

2.  Modification of the Staphylococcus aureus fibronectin binding phenotype by V8 protease.

Authors:  M J McGavin; C Zahradka; K Rice; J E Scott
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

Review 3.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

4.  Selective distribution of a high-affinity plasminogen-binding site among group A streptococci associated with impetigo.

Authors:  M D Svensson; U Sjöbring; D E Bessen
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  Identification of D motif epitopes in Staphylococcus aureus fibronectin-binding protein for the production of antibody inhibitors of fibronectin binding.

Authors:  Q Sun; G M Smith; C Zahradka; M J McGavin
Journal:  Infect Immun       Date:  1997-02       Impact factor: 3.441

6.  M-like proteins of Streptococcus dysgalactiae.

Authors:  J Vasi; L Frykberg; L E Carlsson; M Lindberg; B Guss
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Variance in fibronectin binding and fnb locus polymorphisms in Staphylococcus aureus: identification of antigenic variation in a fibronectin binding protein adhesin of the epidemic CMRSA-1 strain of methicillin-resistant S. aureus.

Authors:  K Rice; M Huesca; D Vaz; M J McGavin
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

8.  The Treatment of Severe Group A Streptococcal Infections.

Authors:  Anna Norrby-Teglund; S. Ragnar Norrby; Donald E. Low
Journal:  Curr Infect Dis Rep       Date:  2003-02       Impact factor: 3.725

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.